- Home
- DERM vs TSE Comparison
DERM vs TSE Comparison
Compare DERM & TSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- TSE
- Stock Information
- Founded
- DERM 2014
- TSE 2010
- Country
- DERM United States
- TSE United States
- Employees
- DERM N/A
- TSE N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- TSE Major Chemicals
- Sector
- DERM Health Care
- TSE Industrials
- Exchange
- DERM Nasdaq
- TSE Nasdaq
- Market Cap
- DERM 181.0M
- TSE 149.4M
- IPO Year
- DERM 2021
- TSE 2014
- Fundamental
- Price
- DERM $8.06
- TSE $3.03
- Analyst Decision
- DERM Strong Buy
- TSE
- Analyst Count
- DERM 2
- TSE 0
- Target Price
- DERM $10.00
- TSE N/A
- AVG Volume (30 Days)
- DERM 103.3K
- TSE 437.8K
- Earning Date
- DERM 05-14-2025
- TSE 05-07-2025
- Dividend Yield
- DERM N/A
- TSE 1.32%
- EPS Growth
- DERM N/A
- TSE N/A
- EPS
- DERM N/A
- TSE N/A
- Revenue
- DERM $56,243,000.00
- TSE $3,394,000,000.00
- Revenue This Year
- DERM $29.83
- TSE $5.72
- Revenue Next Year
- DERM $54.88
- TSE $3.80
- P/E Ratio
- DERM N/A
- TSE N/A
- Revenue Growth
- DERM N/A
- TSE N/A
- 52 Week Low
- DERM $3.54
- TSE $1.94
- 52 Week High
- DERM $8.24
- TSE $7.05
- Technical
- Relative Strength Index (RSI)
- DERM 65.90
- TSE 48.64
- Support Level
- DERM $6.55
- TSE $2.68
- Resistance Level
- DERM $7.00
- TSE $2.98
- Average True Range (ATR)
- DERM 0.63
- TSE 0.21
- MACD
- DERM 0.13
- TSE 0.05
- Stochastic Oscillator
- DERM 92.41
- TSE 83.13
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About TSE Trinseo PLC
Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include Latex Binders, Americas Styrenics, Engineered Materials, and Polymer Solutions. Maximum revenue is generated from its Polymer Solutions segment, which consists of various polymers, the majority of which are for automotive, building, and construction applications. The product offerings of this segment include ABS, styrene-acrylonitrile, polystyrene, and polycarbonate products, which are marketed through brands like Magnum and Styron. Geographically, the company generates maximum revenue from Europe, followed by the United States, Asia-Pacific, and the Rest of the world.